Skip Nav Destination
Article navigation
Meeting Abstracts|
September 1979
BW444U: AN INTERMEDIATE-DURATION NONDEPOLARIZING NEUROMUSCULAR BLOCKING AGENT WITH SIGNIFICANT LACK OF CARDIOVASCULAR AND AUTONOMIC EFFECT
Anesthesia Laboratories, Harvard Medical School at Massachusetts General Hospital, Boston, Massachusetts, and Department of Pharmacology, Wellcome Research Laboratories, Burroughs Wellcome Company, Research Triangle Park, North Carolina
Anesthesiology September 1979, Vol. 51, S280.
Citation
John J. Savarese, William B. Wastila; BW444U: AN INTERMEDIATE-DURATION NONDEPOLARIZING NEUROMUSCULAR BLOCKING AGENT WITH SIGNIFICANT LACK OF CARDIOVASCULAR AND AUTONOMIC EFFECT. Anesthesiology 1979; 51:S280 doi: https://doi.org/10.1097/00000542-197909001-00279
Download citation file:
95
Views
0
Citations
Citing articles via
Most Viewed
Related Articles
Preclinical Pharmacology of CW002: A Nondepolarizing Neuromuscular Blocking Drug of Intermediate Duration, Degraded and Antagonized by l-cysteine—Additional Studies of Safety and Efficacy in the Anesthetized Rhesus Monkey and Cat
Anesthesiology (October 2016)
Residual Paralysis in the PACU after a Single Intubating Dose of Nondepolarizing Muscle Relaxant with an Intermediate Duration of Action
Anesthesiology (May 2003)
The Clinical Neuromuscular Pharmacology of 51W89 in Patients Receiving Nitrous Oxide/Opioid/Barbiturate Anesthesia
Anesthesiology (May 1995)
Nondepolarizing Neuromuscular Blocking Agents, Reversal, and Risk of Postoperative Pneumonia
Anesthesiology (October 2016)
Preclinical Pharmacology of GW280430A (AV430A) in the Rhesus Monkey and in the Cat: A Comparison with Mivacurium
Anesthesiology (April 2004)
